In a written reply, Minister for Chemicals and Fertilisers D V Sadananda Gowda said: "NPPA is monitoring the situation regularly to ensure that ceiling prices of essential medicines are not breached and are available uninterruptedly."
The regulator has not received any reference regarding sudden increase in the price of paracetamol by 40 per cent and azithromycin by 70 per cent in the country, he added.
The NPPA in February wrote to chief secretaries of all the states/UTs to monitor the production and availability of active pharmaceutical ingredients (APIs) and their formulations to prevent black marketing and hoarding and to ensure price compliance as per the Drugs (Prices Control) Order, 2013 (DPCO, 2013), Gowda said.
In reply to another question, Gowda said, "NPPA monitors the prices of medicines on a regular basis to check overcharging by pharmaceutical companies."
Whenever any company is found to be overcharging consumers for a medicine above the ceiling price notified by the NPPA, the regulator issues a notice to such company to deposit the overcharged amount along with applicable interest under section 7A of the Essential Commodities Act, 1955, he added. AKT MKJ